BACKGROUND: We previously established a mesenchymal stem cell line (FMS/PA6-P) from the bone marrow adherent cells of fetal mice. The cell line expresses a higher level of neural cell adhesion molecule and shows greater hematopoiesis-supporting capacity in mice than other murine stromal cell lines. DESIGN AND METHODS: Since there is 94% homology between human and murine neural cell adhesion molecule, we examined whether FMS/PA6-P cells support human hematopoiesis and whether neural cell adhesion molecules expressed on FMS/PA6-P cells contribute greatly to the human hematopoiesis-supporting ability of the cell line. RESULTS: When lineage-negative cord blood mononuclear cells were co-cultured on the FMS/PA6-P cells, a significantly greater hematopoietic stem cell-enriched population (CD34(+)CD38(-) cells) was obtained than in the culture without the FMS/PA6-P cells. Moreover, when lineage-negative cord blood mononuclear cells were cultured on FMS/PA6-P cells and transplanted into SCID mice, a significantly larger proportion of human CD45(+) cells and CD34(+)CD38(-) cells were detected in the bone marrow of SCID mice than in the bone marrow of SCID mice that had received lineage-negative cord blood mononuclear cells cultured without FMS/PA6-P cells. Furthermore, we found that direct cell-to-cell contact between the lineage-negative cord blood mononuclear cells and the FMS/PA6-P cells was essential for the maximum expansion of the mononuclear cells. The addition of anti-mouse neural cell adhesion molecule antibody to the culture significantly inhibited their contact and the proliferation of lineage-negative cord blood mononuclear cells. CONCLUSIONS: These findings suggest that neural cell adhesion molecules expressed on FMS/PA6-P cells play a crucial role in the human hematopoiesis-supporting ability of the cell line.
BACKGROUND: We previously established a mesenchymal stem cell line (FMS/PA6-P) from the bone marrow adherent cells of fetal mice. The cell line expresses a higher level of neural cell adhesion molecule and shows greater hematopoiesis-supporting capacity in mice than other murine stromal cell lines. DESIGN AND METHODS: Since there is 94% homology between human and murine neural cell adhesion molecule, we examined whether FMS/PA6-P cells support human hematopoiesis and whether neural cell adhesion molecules expressed on FMS/PA6-P cells contribute greatly to the human hematopoiesis-supporting ability of the cell line. RESULTS: When lineage-negative cord blood mononuclear cells were co-cultured on the FMS/PA6-P cells, a significantly greater hematopoietic stem cell-enriched population (CD34(+)CD38(-) cells) was obtained than in the culture without the FMS/PA6-P cells. Moreover, when lineage-negative cord blood mononuclear cells were cultured on FMS/PA6-P cells and transplanted into SCIDmice, a significantly larger proportion of humanCD45(+) cells and CD34(+)CD38(-) cells were detected in the bone marrow of SCIDmice than in the bone marrow of SCIDmice that had received lineage-negative cord blood mononuclear cells cultured without FMS/PA6-P cells. Furthermore, we found that direct cell-to-cell contact between the lineage-negative cord blood mononuclear cells and the FMS/PA6-P cells was essential for the maximum expansion of the mononuclear cells. The addition of anti-mouse neural cell adhesion molecule antibody to the culture significantly inhibited their contact and the proliferation of lineage-negative cord blood mononuclear cells. CONCLUSIONS: These findings suggest that neural cell adhesion molecules expressed on FMS/PA6-P cells play a crucial role in the human hematopoiesis-supporting ability of the cell line.
Authors: Jennifer Jaroscak; Kristin Goltry; Alan Smith; Barbara Waters-Pick; Paul L Martin; Timothy A Driscoll; Richard Howrey; Nelson Chao; Judy Douville; Sue Burhop; Pingfu Fu; Joanne Kurtzberg Journal: Blood Date: 2003-02-20 Impact factor: 22.113
Authors: Maroun Khoury; Adam Drake; Qingfeng Chen; Di Dong; Ilya Leskov; Maria F Fragoso; Yan Li; Bettina P Iliopoulou; William Hwang; Harvey F Lodish; Jianzhu Chen Journal: Stem Cells Dev Date: 2011-01-31 Impact factor: 3.272
Authors: Dylana Diaz-Solano; Olga Wittig; Carlos Ayala-Grosso; Rosalinda Pieruzzini; Jose E Cardier Journal: Stem Cells Dev Date: 2012-05-18 Impact factor: 3.272
Authors: Friso G J Calkoen; Carly Vervat; Else Eising; Lisanne S Vijfhuizen; Peter-Bram A C 't Hoen; Marry M van den Heuvel-Eibrink; R Maarten Egeler; Maarten J D van Tol; Lynne M Ball Journal: Haematologica Date: 2015-08-20 Impact factor: 9.941
Authors: Larissa C Hermeto; Rafael DeRossi; Rodrigo J Oliveira; Felipe G Gomes; Wallison R Ferreira; Juliana A Galhardo; Tessie Bm Möck; William Vs Basaglia; Diogo M Fernandes Journal: Int J Burns Trauma Date: 2020-12-15
Authors: Peter E Westerweel; Martin Teraa; Shahin Rafii; Janneke E Jaspers; Ian A White; Andrea T Hooper; Pieter A Doevendans; Marianne C Verhaar Journal: PLoS One Date: 2013-03-28 Impact factor: 3.240
Authors: Maria S Skog; Johanna Nystedt; Matti Korhonen; Heidi Anderson; Timo A Lehti; Maria I Pajunen; Jukka Finne Journal: Stem Cell Res Ther Date: 2016-08-15 Impact factor: 6.832